A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Assessing new blood cells growth after transplant using cord blood units that do not meet FDA guidelines but meet NMDP guidelines
a study on Hematologic Malignancies Inherited Disorders of Metabolism Inherited Abnormalities of Platelets Histiocytic Disorders Acute Myeloid Leukemia Leukemia Acute Lymphoblastic Leukemia Chronic Myeloid Leukemia Hodgkin's Lymphoma Lymphoma Non Hodgkin Lymphoma Multiple Myeloma Disorders of the Immune System Autoimmune Disease Anemia
Hematologic Malignancies Inherited Disorders of Metabolism Inherited Abnormalities of Platelets Histiocytic Disorders Acute Myelogenous Leukemia (AML or ANLL) Acute Lymphoblastic Leukemia (ALL) Other Acute Leukemia Chronic Myelogenous Leukemia (CML) Myelodysplastic (MDS) / Myeloproliferative (MPN) Diseases Other Leukemia Hodgkin Lymphoma Non-hodgkin Lymphoma Multiple Myeloma/ Plasma Cell Disorder (PCD) Inherited Abnormalities of Erythrocyte Differentiation or Function Disorders of the Immune System Autoimmune Diseases Severe Aplastic Anemia Lymphoma Leukemia Multiple Myeloma Neoplasms Precursor Cell Lymphoblastic Leukemia-Lymphoma Leukemia, Myeloid Leukemia, Myelogenous, Chronic, BCR-ABL Positive Hematologic Neoplasms Leukemia, Myeloid, Acute Anemia, Aplastic Congenital Abnormalities Disease Unlicensed CBU
Lead Scientists at UC Health
- Edward Ball, MD (ucsd)
Dr. Ball’s research focuses on the development of monoclonal antibody (mAb)-targeted immunotherapy and its translation to the treatment of patients with malignancy. His lab produced mAbs to myeloid-associated antigens expressed on myeloid leukemia cells.
- Gary Schiller, MD (ucla)
Professor-in-Residence, Medicine. Authored (or co-authored) 74 research publications.
- Mark Walters, MD (ucsf)
The over-arching goal of my research career has been to develop and expand curative therapies for hemoglobin disorders in particular and non-malignant hematopoietic disorders more broadly. I have focused on genome editing approaches most recently, which rely upon modification of autologous hematopoietic cells to elicit a curative effect.
- Thomas Martin (ucsf)
- accepting new patients
- Start Date
- Completion Date
- Center for International Blood and Marrow Transplant Research
- Study Type
- Last Updated